Denali Therapeutics Inc (DNLI)
$21.99
Denali Therapeutics Inc (DNLI) Share Price Forecast
Currently 22 wall-street analysts regularly analyze the financials of Denali Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 22 analysts offering 12-month price forecasts for Denali Therapeutics Inc (DNLI) have a share price target of $56.86. This median of share price forecast represents a 158.57% upside from the latest price of $21.99 as on 27.09.23.
Denali Therapeutics Inc (DNLI) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Denali Therapeutics Inc (DNLI) share price will touch around $56.86 in next 12-months.
Denali Therapeutics Inc (DNLI) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Denali Therapeutics Inc's share price and its median forecast price. As on 27.09.23, the difference is -59%
Denali Therapeutics Inc (DNLI): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Denali Therapeutics Inc (DNLI) Share Price : Analyst Recommendation
Based on 22 analysts tracking and researching Denali Therapeutics Inc (DNLI) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 13 | 12 | 11 |
| Outperform | 8 | 8 | 8 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Denali Therapeutics Inc (DNLI) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Denali Therapeutics Inc (DNLI) is $56.86, offered by 22 analysts offering 12-month price forecasts.
Denali Therapeutics Inc (DNLI) has a maximum of 1.59 upside potential, based on 22 analysts offering 12-month price forecasts.
Based on 22 analysts tracking and researching Denali Therapeutics Inc (DNLI), 86.36% have a buy recommendation. Remaining 13.64% have either sell or hold recommendations.
The latest share price of Denali Therapeutics Inc (DNLI) is $21.99 as of 27/09/2023.
19 of total 22 analysts offering stock ratings for Denali Therapeutics Inc DNLI have recommended buy rating.
₹0 US Stocks a/c Opening Fee